Hypoplastic Left Heart Syndrome Clinical Trial
Official title:
Neurodevelopmental Outcomes and Postoperative Hemodynamics in Children With Hypoplastic Left Heart Syndrome
We believe that how a baby with Hypoplastic Left Heart Syndrome (HLHS)does after a major open
heart operation, measured by things like blood pressure, oxygen saturation, heart rate and
others, may have an impact on development. Studying how post-operative condition impacts
outcomes may help us to protect babies better when they undergo surgery.
This study will look at some of the long-term outcomes of children with HLHS, including both
mental development and quality of life. We will use information from your child's medical
record to see if early oxygen delivery has an impact on later development.
Over the past twenty years, the field of congenital heart disease has been marked by globally
improved survival after complex congenital heart surgery. These improved results are clearly
multi-factorial and include advances in diagnostic technologies, surgical techniques,
perfusion strategies, pharmacologic therapies and perioperative monitoring of tissue oxygen
delivery.
Hypoplastic left heart syndrome (HLHS) represents an extreme form of complex congenital heart
disease in which the infant has prolonged cyanosis and a single systemic right ventricle.
Staged palliation beginning with surgery in the neonatal period is the most common approach
to infants with HLHS. After initial surgical palliation, infants are critically ill due to
ischemia/reperfusion injury from cardiopulmonary bypass, coronary ischemia attributed to
diastolic runoff, reduced total ventricular mass, continued hypoxemia during a time of
increased metabolic demands, and finally, the inherent inefficiency of parallel circulation.
The presence of any one of these physiologic derangements places the infant with HLHS at
great risk for ischemia, organ dysfunction, circulatory collapse and, even, death.
Postoperative monitoring of venous oximetry and, more recently, near infrared spectroscopy,
have identified periods of impaired oxygen delivery and ischemia, allowed for interventions
that enhance oxygen delivery and improved survival after cardiac surgery. Although, an
apparent relationship exists between oxygen delivery and survival after cardiac surgery,
little data is available on the relationship between oxygen delivery and neurodevelopmental
outcomes (inclusive of neurocognitive and neuropsychologic outcomes).
Preliminary data from our center has recently identified that reduced venous oximetry was
associated with adverse neurodevelopmental outcome. These initial findings warrant further
investigation of neurologic injury, specifically, how such morbidity relates to perioperative
ischemia and cerebral oxygen delivery. Hence, the purpose of this study is to understand the
relationship of perioperative tissue dysoxia and long-term neurodevelopmental morbidity in
children subject to oxygen delivery at which neurodevelopment is compromised. Identification
of a critical threshold that may be devastating to a child's neurodevelopment and quality of
life would allow for early intervention, goal-directed therapy and ultimately, improve
outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01215240 -
Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure
|
N/A | |
Completed |
NCT00513240 -
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00156455 -
Sleep Disordered Breathing in Children With Single Ventricle Physiology
|
N/A | |
Terminated |
NCT01445041 -
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01708863 -
A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
|
||
Completed |
NCT01736956 -
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
|
N/A | |
Recruiting |
NCT03406884 -
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
|
Phase 1 | |
Not yet recruiting |
NCT06461676 -
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)
|
Phase 1 | |
Active, not recruiting |
NCT03079401 -
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
|
Phase 1/Phase 2 | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Completed |
NCT01883076 -
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Completed |
NCT04056416 -
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
|
N/A | |
Completed |
NCT01656941 -
Genetic Determinants of Congenital Heart Disease Outcomes
|
||
Active, not recruiting |
NCT03779711 -
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
|
Phase 2 | |
Recruiting |
NCT04925024 -
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
|
Phase 2 | |
Recruiting |
NCT02781922 -
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
|
Phase 3 | |
Completed |
NCT01582529 -
SVRII Family Factors Study
|
||
Completed |
NCT00974025 -
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
|
N/A |